Long‐Term Follow‐Up of Prophylactic Implantable Cardioverter‐Defibrillator–Only Therapy: Comparison of Ischemic and Nonischemic Heart Disease
- 28 October 2011
- journal article
- Published by Wiley in Clinical Cardiology
- Vol. 34 (12), 761-767
- https://doi.org/10.1002/clc.20970
Abstract
Background: The benefits of primary prophylactic implantable cardioverter‐defibrillators (ICDs) are actually debated, as some drawbacks become more apparent and as the natural history of cardiac disease seems to improve. Therefore, contemporary follow‐up data of non‐trial populations treated according to current guidelines remain necessary. The aim of this study was to evaluate mortality and the occurrence of ICD interventions in patients with coronary artery disease (CAD) and dilated cardiomyopathy (DCM) who received in the recent era a primary prophylactic ICD without resynchronization therapy. Hypothesis: Survival and event‐free rates from appropriate ICD therapy are different between ischemic and nonischemic ICD patients. Methods: Prospective cohort study of 427 consecutive primary prevention ICD patients with ischemic or nonischemic heart disease, excluding patients with resynchronization. Results: Ischemic heart disease was present in 290 patients (68%), nonischemic heart disease in 137 patients (32%). During a median follow‐up of 31 months (interquartile range [IQR] 15–45 months), 30 patients (7%) died. Mortality was not different in both disease categories. The incidence of appropriate ICD interventions was similar in CAD and DCM (23% vs 21%). Appropriate ICD intervention occurred more frequently in patients with atrial fibrillation (29% vs 19%). Inappropriate ICD intervention occurred in 11% of patients. Conclusions: The clinical course of ischemic and nonischemic heart disease patients treated with a primary prophylactic ICD is similar with respect to mortality and to appropriate and inappropriate ICD interventions, in spite of a younger age at baseline of the DCM patients. © 2011 Wiley Periodicals, Inc. This work was partly funded by “het College Voor Zorgverzekeringen” (OP 0864207). Dr. D.A.M.J. Theuns received research grants from Biotronik, Boston Scientific, and St. Jude Medical, and he is a consultant to Cameron Health (USA). L. Jordaens received research grants and speaker fees from Biotronik, Boston Scientific, Cameron Health, Medtronic, Sorin, and St. Jude Medical. T. Smith and K. Caliskan had no funding, financial relationships, or conflicts of interest to declare.Keywords
This publication has 31 references indexed in Scilit:
- Do some implant too many defibrillators or others too few?EP Europace, 2009
- Implantable Cardioverter Defibrillator Therapy for Primary Prevention of Sudden Cardiac Death after Myocardial Infarction:Pacing and Clinical Electrophysiology, 2009
- Clinical and arrhythmic outcomes after implantation of a defibrillator for primary prevention of sudden death in patients with post-myocardial infarction cardiomyopathy: The Survey to Evaluate Arrhythmia Rate in High-risk MI patients (SEARCH-MI)EP Europace, 2008
- Prognostic Importance of Defibrillator Shocks in Patients with Heart FailureNew England Journal of Medicine, 2008
- Time‐Dependence of Appropriate Implantable Defibrillator Therapy in Patients with Ischemic CardiomyopathyJournal of Cardiovascular Electrophysiology, 2008
- Atrial fibrillation predicts appropriate shocks in primary prevention implantable cardioverter-defibrillator patientsEP Europace, 2006
- Multicenter experience with failed and recalled implantable cardioverter-defibrillator pulse generatorsHeart Rhythm, 2006
- Clinical variables predicting inappropriate use of implantable cardioverter-defibrillator in patients with coronary heart disease or nonischemic dilated cardiomyopathyThe American Journal of Cardiology, 2005
- Prevention of inappropriate therapy in implantable cardioverter-defibrillatorsJournal of the American College of Cardiology, 2004
- Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection FractionNew England Journal of Medicine, 2002